UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4877-4883

2010

Volltextzugriff (PDF)

A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer

The Journal of urology, 2012-12, Vol.188 (6), p.2391-2397

2012

Volltextzugriff (PDF)

Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer

Clinical cancer research, 2016-03, Vol.22 (6), p.1356-1363

2016

Volltextzugriff (PDF)

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Journal of clinical oncology, 2023-01, Vol.41 (2), p.186-197

2023

Volltextzugriff (PDF)

Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors

Cancer chemotherapy and pharmacology, 2013-06, Vol.71 (6), p.1635-1643

2013

Volltextzugriff (PDF)

Association Between Birth Weight Z-Scores and Early Outcomes Following Truncus Arteriosus Repair

Pediatric cardiology, 2023-04, Vol.44 (4), p.741-747

2023

Volltextzugriff (PDF)

Correction to: Association Between Birth Weight Z-Scores and Early Outcomes Following Truncus Arteriosus Repair

Pediatric cardiology, 2023-04, Vol.44 (4), p.963-963

2023

Volltextzugriff (PDF)

Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial

Leukemia & lymphoma, 2009-01, Vol.50 (8), p.1336-1344

2009

Volltextzugriff (PDF)

Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses

International journal of oncology, 2006-03, Vol.28 (3), p.585-593

2006

Volltextzugriff (PDF)

Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response : A pilot study

Oncology reports, 2007-09, Vol.18 (3), p.665-671

2007

Volltextzugriff (PDF)

Increased Dose Intensity of SGN-33, a Humanized Monoclonal Antibody Targeting CD33, Is Active and Well-Tolerated in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Blood, 2006-11, Vol.108 (11), p.4568-4568

2006

Volltextzugriff (PDF)

Troxacitabine, an l-Stereoisomeric Nucleoside Analog, on a Five-Times-Daily Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies

Journal of clinical oncology, 2002-01, Vol.20 (1), p.96-109

de Bono, J. S.

2002

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of BMS-184476, a Taxane With Greater Potency and Solubility Than Paclitaxel

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2493-2503

2001

Volltextzugriff (PDF)

Troxacitabine, an l-stereoisomeric nucleoside analog, on a five-times-daily schedule: A phase I and pharmacokinetic study in patients with advanced solid malignancies

Journal of clinical oncology, 2002, Vol.20 (1), p.96-109

2002

Volltextzugriff (PDF)

High-Dose Taxol, Cyclophosphamide, and Cisplatin with Stem Cell Support in the Treatment of Metastatic Breast Cancer

The breast journal, 1998-05, Vol.4 (3), p.165-170

1998

Volltextzugriff (PDF)

Shining Light on Photoredox Catalysis: Theory and Synthetic Applications

Journal of organic chemistry, 2012-02, Vol.77 (4), p.1617-1622

2012

Volltextzugriff (PDF)

Visible-Light Photoredox Catalysis in Flow

Angewandte Chemie International Edition, 2012-04, Vol.51 (17), p.4144-4147

International ed. in English, 2012

Volltextzugriff (PDF)

Intermolecular Atom Transfer Radical Addition to Olefins Mediated by Oxidative Quenching of Photoredox Catalysts

Journal of the American Chemical Society, 2011-03, Vol.133 (12), p.4160-4163

2011

Volltextzugriff (PDF)

Electron-Transfer Photoredox Catalysis: Development of a Tin-Free Reductive Dehalogenation Reaction

Journal of the American Chemical Society, 2009-07, Vol.131 (25), p.8756-8757

2009

Volltextzugriff (PDF)

Tandem Visible Light-Mediated Radical Cyclization–Divinylcyclopropane Rearrangement to Tricyclic Pyrrolidinones

Organic letters, 2011-10, Vol.13 (20), p.5468-5471

2011

Volltextzugriff (PDF)

Electron Transfer Photoredox Catalysis: Intramolecular Radical Addition to Indoles and Pyrroles

Organic letters, 2010-01, Vol.12 (2), p.368-371

2010

Volltextzugriff (PDF)

Acceptability of using electronic vending machines to deliver oral rapid HIV self-testing kits: a qualitative study

PloS one, 2014-07, Vol.9 (7), p.e103790-e103790

2014

Volltextzugriff (PDF)

Oxidative photoredox catalysis: mild and selective deprotection of PMB ethers mediated by visible light

Chemical communications (Cambridge, England), 2011-01, Vol.47 (17), p.5040-5042

2011

Volltextzugriff (PDF)

Visible Light-Mediated Intermolecular C−H Functionalization of Electron-Rich Heterocycles with Malonates

Organic letters, 2010-07, Vol.12 (13), p.3104-3107

2010

Volltextzugriff (PDF)

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

Journal of neurology, 2015-05, Vol.262 (5), p.1344-1353

2015

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(247)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer

Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134

Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors

Association Between Birth Weight Z-Scores and Early Outcomes Following Truncus Arteriosus Repair

Correction to: Association Between Birth Weight Z-Scores and Early Outcomes Following Truncus Arteriosus Repair

Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial

Dendritoma vaccination combined with low dose interleukin-2 in metastatic melanoma patients induced immunological and clinical responses

Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response : A pilot study

Increased Dose Intensity of SGN-33, a Humanized Monoclonal Antibody Targeting CD33, Is Active and Well-Tolerated in Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Troxacitabine, an l-Stereoisomeric Nucleoside Analog, on a Five-Times-Daily Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies

Phase I and Pharmacokinetic Study of BMS-184476, a Taxane With Greater Potency and Solubility Than Paclitaxel

Troxacitabine, an l-stereoisomeric nucleoside analog, on a five-times-daily schedule: A phase I and pharmacokinetic study in patients with advanced solid malignancies

High-Dose Taxol, Cyclophosphamide, and Cisplatin with Stem Cell Support in the Treatment of Metastatic Breast Cancer

Shining Light on Photoredox Catalysis: Theory and Synthetic Applications

Visible-Light Photoredox Catalysis in Flow

Intermolecular Atom Transfer Radical Addition to Olefins Mediated by Oxidative Quenching of Photoredox Catalysts

Electron-Transfer Photoredox Catalysis: Development of a Tin-Free Reductive Dehalogenation Reaction

Tandem Visible Light-Mediated Radical Cyclization–Divinylcyclopropane Rearrangement to Tricyclic Pyrrolidinones

Electron Transfer Photoredox Catalysis: Intramolecular Radical Addition to Indoles and Pyrroles

Acceptability of using electronic vending machines to deliver oral rapid HIV self-testing kits: a qualitative study

Oxidative photoredox catalysis: mild and selective deprotection of PMB ethers mediated by visible light

Visible Light-Mediated Intermolecular C−H Functionalization of Electron-Rich Heterocycles with Malonates

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

Suchergebnisse filtern